Comment on ‘Nomogram to predict pathologic complete response in HER2-positive breast cancer treated with neoadjuvant systemic therapy’

Comment on 'Nomogram to predict pathologic complete response in HER2-positive breast cancer treated with neoadjuvant systemic therapy'

British Journal of Cancer 116, e10 (11 April 2017). doi:10.1038/bjc.2017.60

Author: Kadri Altundag

http://ift.tt/2mq9Mvm